Research & Development

Today we are speaking with Ivan Kairatov, a biopharma expert whose work at the intersection of public health and cancer epidemiology sheds light on one of the world’s most preventable cancers. We’ll be exploring the complex story behind cervical cancer: a disease for which we have the tools to

For millions grappling with the profound and persistent darkness of major depression, the journey to find an effective treatment can be a long and disheartening road, but a landmark clinical trial has now provided powerful evidence that an implanted medical device offers substantial and lasting

The allure of a cut-price cosmetic procedure or weight-loss surgery abroad often masks a harsh reality, one where complications can leave UK patients facing a health crisis and the National Health Service footing a bill that can spiral into tens of thousands of pounds. This growing trend of

The ability to track cancer's genetic secrets through a simple blood draw is no longer a futuristic concept but a clinical reality facing its own set of critical challenges. For years, the field of oncology has been steadily moving away from invasive tissue biopsies toward liquid biopsies, a

Biopharma expert Ivan Kairatov joins us to discuss a groundbreaking advance in immunotherapy. While treatments like CAR-T cell therapy have shown incredible promise, they are not a solution for every patient, often because the necessary immune cells are rare or difficult to work with. Now,

A formidable new strategy has emerged in the fight against a particularly stubborn form of lung cancer, offering a beacon of hope for patients whose tumors have developed resistance to frontline treatments. Researchers from the Medical University of Vienna have pioneered a novel combination therapy